We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

Intrathecal Chemotherapy

In 2014, an Intrathecal Chemotherapy Project Board was established to develop recommendations on intrathecal chemotherapy and neurotoxic drugs, in response to Recommendation 71 of the NCCP Oncology Medication Safety Review.

The Intrathecal Chemotherapy Project Board produced four guidance documents, which were endorsed by the Oncology Medication Review Implementation Steering Group in November 2015.

The documents are available below:

NCCP Guidance on the Use of Intrathecal Chemotherapy in the Treatment of Cancer

NCCP Guidance on the Use of Neurotoxic Drugs (including Vinca Alkaloids) in the Treatment of Cancer